<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://www.modernmedicine.com/modernmedicine/servlet/modernmedicine_41766.rss?id=41766">
    <title>Modern Medicine - Dry Eye</title>

    <link>http://www.modernmedicine.com/modernmedicine/Dry+Eye/Article/list/41766</link>

    <description>View news and clinical articles about the condition known as Dry Eye in this section. Also known as
    Keratoconjunctivitis Sicca (KCS) or Dry Eye Syndrome, Dry Eye is an eye disease caused by decreased tear production
    or increased tear film evaporation. This Condition Center page provides new and clinical articles about dry
    eye.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laser-Treated-Corneas-Found-Suitable-for-Donor-Tis/ArticleNewsFeed/Article/detail/643381?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Endocrinology/Drug-May-Reverse-Type-1-Diabetes-Ocular-Complicati/ArticleNewsFeed/Article/detail/642027?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Retinal+Disease/Cataract-Surgery-Unlikely-to-Affect-the-Progressio/ArticleNewsFeed/Article/detail/642025?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Hemoglobin-A1C-Levels-May-Be-Better-Predictor-of-R/ArticleNewsFeed/Article/detail/641798?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-Surgery-May-Benefit-Macular-Degeneration/ArticleNewsFeed/Article/detail/640328?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cellular-Pathway-Implicated-in-Diabetic-Retinopath/ArticleNewsFeed/Article/detail/640100?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Looks-at-Five-Year-Effect-of-Treatment-in-Ma/ArticleNewsFeed/Article/detail/639867?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/October-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/638301?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAO-Barriers-to-Care-Among-Glaucoma-Patients-Exami/ArticleNewsFeed/Article/detail/637052?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAO-Myopia-May-Reduce-Risk-of-Diabetic-Retinopathy/ArticleNewsFeed/Article/detail/637054?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Gene-Therapy-Shows-Promise-in-Inherited-Sight-Diso/ArticleNewsFeed/Article/detail/636525?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Normal-Tension-Glaucoma-Treatment-Options-Explored/ArticleNewsFeed/Article/detail/634414?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/More-Very-Preterm-Births-Is-Raising-Retinopathy-In/ArticleNewsFeed/Article/detail/634219?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Endocrinology/Study-Evaluates-Hospital-Quality-and-Mortality-Rat/ArticleNewsFeed/Article/detail/633747?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Early-AMD-May-Increase-Heart-Disease-Risk-in-Older/ArticleNewsFeed/Article/detail/633746?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Visual-Impairment-May-Affect-Mortality-Risk-in-Eld/ArticleNewsFeed/Article/detail/633520?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Midlife-Vision-Linked-to-Early-Childhood-Factors/ArticleNewsFeed/Article/detail/632260?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Low-Contrast-Visibility-May-Be-Issue-for-Parkinson/ArticleNewsFeed/Article/detail/631866?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Visual-Loss-Lower-in-Recently-Diagnosed-Type-1-Dia/ArticleNewsFeed/Article/detail/632032?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Clinical+News/FDA-approves-Sirions-NDA-for-ganciclovir-015-for-h/ArticleStandard/Article/detail/631228?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/September-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/630888?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Better-Stove-May-Improve-Womens-Respiratory-Health/ArticleNewsFeed/Article/detail/629587?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Nursing/Childhood-Nephrotic-Syndrome-Can-Cause-Lifelong-Il/ArticleNewsFeed/Article/detail/629418?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Triamcinolone-Studied-for-Vision-Loss-in-Macular-E/ArticleNewsFeed/Article/detail/626778?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Corneal-Transplant-Method-Appears-Safe-and-Effecti/ArticleNewsFeed/Article/detail/624688?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antibiotic-Class-Linked-to-Double-Vision/ArticleNewsFeed/Article/detail/624692?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Sodium-hyaluronate-solution-safe-effective/ArticleStandard/Article/detail/627671?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/August-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/623314?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-disease-more-common-in-American-men-as-the/ArticleStandard/Article/detail/627288?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pluripotent-Stem-Cells-Aid-in-Exploring-Retinal-De/ArticleNewsFeed/Article/detail/623035?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Healing-Impaired-in-Leaking-Blebs-After-Glaucoma-S/ArticleNewsFeed/Article/detail/620722?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Scleral-Invasion-Linked-to-Risk-of-Relapse-in-Reti/ArticleNewsFeed/Article/detail/620720?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Uveal-Melanoma-Thickness-Associated-With-Metastasi/ArticleNewsFeed/Article/detail/618538?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Bevacizumab-Benefits-Seen-in-Forms-of-Macular-Edem/ArticleNewsFeed/Article/detail/617422?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Endocrinology/Cataract-Surgery-Associated-With-Diabetic-Eye-Prob/ArticleNewsFeed/Article/detail/617424?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/July-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/615999?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Blepharitis-prevalence-and-management-studied-in-r/ArticleStandard/Article/detail/617067?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Endocrinology/Type-1-Diabetes-Complications-Becoming-Less-Common/ArticleNewsFeed/Article/detail/614917?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antihypertensive-Drugs-Associated-With-Cataracts/ArticleNewsFeed/Article/detail/613458?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Post-LASIK-healing-rate-may-be-increased-by-hyprom/ArticleStandard/Article/detail/610905?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patients-with-dry-eye-find-symptom-relief-quality-/ArticleStandard/Article/detail/610903?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/When-using-punctal-plugs-for-dry-eye-surgeon-favor/ArticleStandard/Article/detail/610889?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Osmometer-comparison-shows-newer-technology-allows/ArticleStandard/Article/detail/610893?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Epinastine-HCl-shows-utility-in-dry-eye-allergy/ArticleStandard/Article/detail/610895?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Intraductal-meibomian-gland-probing-reduces-inflam/ArticleStandard/Article/detail/610890?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-progression-prevented-by-cyclosporine/ArticleStandard/Article/detail/610891?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/PostLASIK-dry-eye-treatment-using-sodium-hyalurona/ArticleStandard/Article/detail/610904?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Posterior-Chamber-Lens-Shows-Years-of-Benefit-in-M/ArticleNewsFeed/Article/detail/611377?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Artificial-tear-product-improves-functional-visual/ArticleStandard/Article/detail/610896?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-drop-formulation-found-effective-for-post-LASI/ArticleStandard/Article/detail/610897?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Inflammation-Is-Linked-to-Corneal-Transplant-Rejec/ArticleNewsFeed/Article/detail/609607?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/June-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/608156?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-diagnosis-could-be-aided-by-tear-osmolarit/ArticleStandard/Article/detail/606431?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Protein-Target-Key-to-Prevent-Macular-Degenera/ArticleNewsFeed/Article/detail/604536?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Approaching-the-patient-with-chronic-eye-irritatio/ArticleStandard/Article/detail/601870?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Managed+Care/Dry-Eye-Affects-168-Million-Older-Men-in-US/ArticleNewsFeed/Article/detail/603019?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Childhood-Eye-Condition-Linked-to-Psychiatric-Diso/ArticleNewsFeed/Article/detail/602761?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-Bacteria-Getting-More-Resistant-to-Older-Antib/ArticleNewsFeed/Article/detail/601743?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patient-Factors-Identified-Affecting-Corneal-Graft/ArticleNewsFeed/Article/detail/601808?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patient-Factors-Affect-Glaucoma-Eyedrop-Adherence/ArticleNewsFeed/Article/detail/601476?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/May-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/600952?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleNewsFeed/Article/detail/598381?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Key-Nutrients-Lower-Risk-of-Macular-Degeneration/ArticleNewsFeed/Article/detail/597339?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/April-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/596174?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ophthalmologys-underserved-areas-to-be-addressed-b/ArticleStandard/Article/detail/599641?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Clinical+News/Cyclosporine-for-dry-eye-shows-significant-improve/ArticleStandard/Article/detail/596113?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Drugs-Effect-on-Macular-Edema-in-Type-2-Diabetics-/ArticleNewsFeed/Article/detail/593948?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Stem-Cells-Repair-Corneal-Damage-in-Mice/ArticleNewsFeed/Article/detail/593862?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Vision-Safety-of-Erectile-Dysfunction-Drugs-Examin/ArticleNewsFeed/Article/detail/593483?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Repetitive-Training-Offers-Benefits-After-Cortex-D/ArticleNewsFeed/Article/detail/592194?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/About-3-Percent-of-US-Children-Have-Hearing-Loss/ArticleNewsFeed/Article/detail/592195?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/LASIK-Linked-to-High-Patient-Satisfaction-Rates/ArticleNewsFeed/Article/detail/591830?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Inhaled-and-Oral-Corticosteroid-Link-to-Cataracts-/ArticleNewsFeed/Article/detail/591521?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/March-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/590883?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laser-vision-correction-procedures-improved-by-pha/ArticleStandard/Article/detail/593677?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Mass-Antibiotic-Program-Can-Offer-Trachoma-Herd-Pr/ArticleNewsFeed/Article/detail/589743?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/US-Diabetic-Retinopathy-Cases-Set-to-Triple-by-205/ArticleNewsFeed/Article/detail/586610?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Insurance-Status-Affects-Access-to-Eye-Care/ArticleNewsFeed/Article/detail/586067?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Macular-Degeneration-Linked-with-Range-of-Illnesse/ArticleNewsFeed/Article/detail/586065?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/February-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/584213?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/For-dry-eye-patients-punctal-plugs-offer-flow-cont/ArticleStandard/Article/detail/585651?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Calcium-Other-Nutrients-May-Reduce-Disease-Risk/ArticleNewsFeed/Article/detail/583396?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ocular-Damage-Common-in-Severe-Skin-Reactions/ArticleNewsFeed/Article/detail/582431?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-Problems-Found-in-Many-Children-with-Hearing-L/ArticleNewsFeed/Article/detail/582350?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ecabet-shows-promise-for-dry-eye-in-phase-IIb-stud/ArticleStandard/Article/detail/582497?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Bepotastine-is-effective-against-allergic-conjunct/ArticleStandard/Article/detail/582491?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-in-patients-undergoing-LASIK-requires-proa/ArticleStandard/Article/detail/582495?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-and-allergy-clues-are-right-before-your-ey/ArticleStandard/Article/detail/582496?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anti-allergy-drop-does-not-cause-dryness-to-ocular/ArticleStandard/Article/detail/582493?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ophthalmologists-perception-of-moderate-to-severe-/ArticleStandard/Article/detail/582501?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-drops-for-contact-lens-wearers-are-found-to-be/ArticleStandard/Article/detail/582498?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-common-postLASIK----and-before/ArticleStandard/Article/detail/582499?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lipid-emulsion-benefits-dry-eye-disease-says-docto/ArticleStandard/Article/detail/582500?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-drops-and-the-different-implications-for-p/ArticleStandard/Article/detail/582490?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-treatment-should-be-tailored-to-patient/ArticleStandard/Article/detail/582492?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Better-Visual-Field-Sight-with-Vigabatrin-During-I/ArticleNewsFeed/Article/detail/580874?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Topical-Cyclosporine-Beneficial-in-Dry-Eye-Syndrom/ArticleNewsFeed/Article/detail/580745?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anecortave-Acetate-Reduces-Ocular-Hypertension/ArticleNewsFeed/Article/detail/580603?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Trichloramine-at-Ohio-Waterpark-Sickened-665-Peopl/ArticleNewsFeed/Article/detail/580441?contextCategoryId=41766&amp;ref=25" />

        <rdf:li
        resource="http://www.modernmedicine.com/modernmedicine/Clinical+News/ISTA-announces-results-of-phase-IIb-study-of-ecabe/ArticleStandard/Article/detail/579948?contextCategoryId=41766&amp;ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2009-11-21T20:53:17Z</dc:date>
  </channel>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laser-Treated-Corneas-Found-Suitable-for-Donor-Tis/ArticleNewsFeed/Article/detail/643381?contextCategoryId=41766&amp;ref=25">

    <title>Laser-Treated Corneas Found Suitable for Donor Tissue</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laser-Treated-Corneas-Found-Suitable-for-Donor-Tis/ArticleNewsFeed/Article/detail/643381?contextCategoryId=41766&amp;ref=25</link>

    <description>Laser in situ keratomileusis and photorefractive keratectomy are not likely associated with any
    significant long-term effect on the corneal endothelium, and may be used as donor tissue, according to a study
    published in the November issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-11-20T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/643381/eye_SS36015.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/643381null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Endocrinology/Drug-May-Reverse-Type-1-Diabetes-Ocular-Complicati/ArticleNewsFeed/Article/detail/642027?contextCategoryId=41766&amp;ref=25">

    <title>Drug May Reverse Type 1 Diabetes Ocular Complications</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Endocrinology/Drug-May-Reverse-Type-1-Diabetes-Ocular-Complicati/ArticleNewsFeed/Article/detail/642027?contextCategoryId=41766&amp;ref=25</link>

    <description>In rats induced with type 1 diabetes, topical treatment with naltrexone hydrochloride, an opioid
    antagonist, reverses dry eye and restores corneal sensitivity, according to a study in the November issue of the
    Archives of Ophthalmology.</description>

    <dc:date>2009-11-16T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642027/eyedrop_59237.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642027null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Retinal+Disease/Cataract-Surgery-Unlikely-to-Affect-the-Progressio/ArticleNewsFeed/Article/detail/642025?contextCategoryId=41766&amp;ref=25">

    <title>Cataract Surgery Unlikely to Affect the Progression of AMD</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Retinal+Disease/Cataract-Surgery-Unlikely-to-Affect-the-Progressio/ArticleNewsFeed/Article/detail/642025?contextCategoryId=41766&amp;ref=25</link>

    <description>In patients with non-neovascular age-related macular degeneration (AMD), cataract surgery is not
    associated with an increased risk of AMD progression. In addition, dietary fats may have differential effects on
    the risk of AMD, according to two studies in the November issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-11-16T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642025/SS36006.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642025null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Hemoglobin-A1C-Levels-May-Be-Better-Predictor-of-R/ArticleNewsFeed/Article/detail/641798?contextCategoryId=41766&amp;ref=25">

    <title>Hemoglobin A1C Levels May Be Better Predictor of Retinopathy</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Hemoglobin-A1C-Levels-May-Be-Better-Predictor-of-R/ArticleNewsFeed/Article/detail/641798?contextCategoryId=41766&amp;ref=25</link>

    <description>Hemoglobin A1C levels are a better predictor of retinopathy than fasting plasma glucose, according to
    a study in the November Diabetes Care. In a related study in the same issue, researchers report that routine
    lowering of blood pressure and intensive glucose control substantially improve renal outcomes and reduces death in
    type 2 diabetes patients.</description>

    <dc:date>2009-11-13T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/641798/Sen002ml.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/641798null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-Surgery-May-Benefit-Macular-Degeneration/ArticleNewsFeed/Article/detail/640328?contextCategoryId=41766&amp;ref=25">

    <title>Cataract Surgery May Benefit Macular Degeneration</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-Surgery-May-Benefit-Macular-Degeneration/ArticleNewsFeed/Article/detail/640328?contextCategoryId=41766&amp;ref=25</link>

    <description>Individuals with varying degrees of age-related macular degeneration may benefit in terms of visual
    acuity from cataract surgery, according to the Age-Related Eye Disease Study published in the November issue of
    Ophthalmology.</description>

    <dc:date>2009-11-09T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640328/eyechart.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640328null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cellular-Pathway-Implicated-in-Diabetic-Retinopath/ArticleNewsFeed/Article/detail/640100?contextCategoryId=41766&amp;ref=25">

    <title>Cellular Pathway Implicated in Diabetic Retinopathy</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cellular-Pathway-Implicated-in-Diabetic-Retinopath/ArticleNewsFeed/Article/detail/640100?contextCategoryId=41766&amp;ref=25</link>

    <description>An additional cellular signaling pathway activated by hyperglycemia is involved in the death of
    retinal cells that lead to diabetic retinopathy, according to a study published online Nov. 1 in Nature
    Medicine.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/640100/Sen002ml.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/640100null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Looks-at-Five-Year-Effect-of-Treatment-in-Ma/ArticleNewsFeed/Article/detail/639867?contextCategoryId=41766&amp;ref=25">

    <title>Study Looks at Five-Year Effect of Treatment in Macular Edema</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Looks-at-Five-Year-Effect-of-Treatment-in-Ma/ArticleNewsFeed/Article/detail/639867?contextCategoryId=41766&amp;ref=25</link>

    <description>Intravitreal triamcinolone acetonide may be helpful in treating some cases of advanced diabetic
    macular edema, according to research published in the November issue of Ophthalmology.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/639867/SS36006.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/639867null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/October-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/638301?contextCategoryId=41766&amp;ref=25">

    <title>October 2009 Briefing - Ophthalmology</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/October-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/638301?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/638301null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAO-Barriers-to-Care-Among-Glaucoma-Patients-Exami/ArticleNewsFeed/Article/detail/637052?contextCategoryId=41766&amp;ref=25">

    <title>AAO: Barriers to Care Among Glaucoma Patients Examined</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAO-Barriers-to-Care-Among-Glaucoma-Patients-Exami/ArticleNewsFeed/Article/detail/637052?contextCategoryId=41766&amp;ref=25</link>

    <description>Simple clinic management issues, such as long waiting times and difficulty scheduling appointments,
    were cited as the primary barriers to optimal follow-up care among glaucoma patients, according to research
    presented at the fourth annual joint meeting of the American Academy of Ophthalmology and the Pan-American
    Association of Ophthalmology, held from Oct. 24 to 27 in San Francisco.</description>

    <dc:date>2009-10-27T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637052/eyechart.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637052null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAO-Myopia-May-Reduce-Risk-of-Diabetic-Retinopathy/ArticleNewsFeed/Article/detail/637054?contextCategoryId=41766&amp;ref=25">

    <title>AAO: Myopia May Reduce Risk of Diabetic Retinopathy</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAO-Myopia-May-Reduce-Risk-of-Diabetic-Retinopathy/ArticleNewsFeed/Article/detail/637054?contextCategoryId=41766&amp;ref=25</link>

    <description>People with diabetes who are nearsighted are at reduced risk for developing diabetic retinopathy and
    vision-threatening diabetic retinopathy, according to research presented at the fourth annual joint meeting of the
    American Academy of Ophthalmology and the Pan-American Association of Ophthalmology, held from Oct. 24 to 27 in San
    Francisco.</description>

    <dc:date>2009-10-27T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637054/eyeexam_40291.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637054null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Gene-Therapy-Shows-Promise-in-Inherited-Sight-Diso/ArticleNewsFeed/Article/detail/636525?contextCategoryId=41766&amp;ref=25">

    <title>Gene Therapy Shows Promise in Inherited Sight Disorder</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Gene-Therapy-Shows-Promise-in-Inherited-Sight-Diso/ArticleNewsFeed/Article/detail/636525?contextCategoryId=41766&amp;ref=25</link>

    <description>Gene therapy for a rare inherited sight disorder in which severely impaired vision in childhood
    usually results in blindness in adulthood can substantially improve vision, particularly in children, according to
    a study published online Oct. 24 in The Lancet.</description>

    <dc:date>2009-10-26T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/636525/sight_18121.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/636525null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Normal-Tension-Glaucoma-Treatment-Options-Explored/ArticleNewsFeed/Article/detail/634414?contextCategoryId=41766&amp;ref=25">

    <title>Normal-Tension Glaucoma Treatment Options Explored</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Normal-Tension-Glaucoma-Treatment-Options-Explored/ArticleNewsFeed/Article/detail/634414?contextCategoryId=41766&amp;ref=25</link>

    <description>Untreated intraocular pressure and zone &amp;amp;beta; variables of peripapillary atrophy may serve as
    risk factors for normal-tension glaucoma in young individuals with moderate to severe vision loss, according to a
    study in the October issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-10-15T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/634414/eye_40179.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/634414null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/More-Very-Preterm-Births-Is-Raising-Retinopathy-In/ArticleNewsFeed/Article/detail/634219?contextCategoryId=41766&amp;ref=25">

    <title>More Very Preterm Births Is Raising Retinopathy Incidence</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/More-Very-Preterm-Births-Is-Raising-Retinopathy-In/ArticleNewsFeed/Article/detail/634219?contextCategoryId=41766&amp;ref=25</link>

    <description>The increasing number of extremely preterm babies who are surviving is increasing the incidence of
    retinopathy of prematurity, according to a study published in the October issue of the Archives of
    Ophthalmology.</description>

    <dc:date>2009-10-14T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/634219/babyeye_SS36028.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/634219null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Endocrinology/Study-Evaluates-Hospital-Quality-and-Mortality-Rat/ArticleNewsFeed/Article/detail/633747?contextCategoryId=41766&amp;ref=25">

    <title>Study Evaluates Hospital Quality and Mortality Rates</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Endocrinology/Study-Evaluates-Hospital-Quality-and-Mortality-Rat/ArticleNewsFeed/Article/detail/633747?contextCategoryId=41766&amp;ref=25</link>

    <description>Hospital mortality rates in the United States have improved, although major differences in quality
    still exist between the best and worst hospitals, according to a report published Oct. 13 by
    HealthGrades.</description>

    <dc:date>2009-10-13T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633747/hospitalsign_18169.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633747null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Early-AMD-May-Increase-Heart-Disease-Risk-in-Older/ArticleNewsFeed/Article/detail/633746?contextCategoryId=41766&amp;ref=25">

    <title>Early AMD May Increase Heart Disease Risk in Older Adults</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Early-AMD-May-Increase-Heart-Disease-Risk-in-Older/ArticleNewsFeed/Article/detail/633746?contextCategoryId=41766&amp;ref=25</link>

    <description>Older adults with early age-related macular degeneration may be at higher risk of coronary heart
    disease, according to the Cardiovascular Health Study published in the October issue of
    Ophthalmology.</description>

    <dc:date>2009-10-13T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633746/eyechart_59082.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633746null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Visual-Impairment-May-Affect-Mortality-Risk-in-Eld/ArticleNewsFeed/Article/detail/633520?contextCategoryId=41766&amp;ref=25">

    <title>Visual Impairment May Affect Mortality Risk in Elders</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Visual-Impairment-May-Affect-Mortality-Risk-in-Eld/ArticleNewsFeed/Article/detail/633520?contextCategoryId=41766&amp;ref=25</link>

    <description>Visual impairment that cannot be corrected increases the odds of mortality in older adults, especially
    among those younger than 75, according to a study published in the October issue of the Archives of
    Ophthalmology.</description>

    <dc:date>2009-10-12T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633520/eyechart_SS36019.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633520null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Midlife-Vision-Linked-to-Early-Childhood-Factors/ArticleNewsFeed/Article/detail/632260?contextCategoryId=41766&amp;ref=25">

    <title>Midlife Vision Linked to Early Childhood Factors</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Midlife-Vision-Linked-to-Early-Childhood-Factors/ArticleNewsFeed/Article/detail/632260?contextCategoryId=41766&amp;ref=25</link>

    <description>Prenatal, childhood biological and social determinants may contribute to midlife visual function,
    according to a study in the October issue of Ophthalmology.</description>

    <dc:date>2009-10-07T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/632260/eyeexam_40291.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/632260null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Low-Contrast-Visibility-May-Be-Issue-for-Parkinson/ArticleNewsFeed/Article/detail/631866?contextCategoryId=41766&amp;ref=25">

    <title>Low-Contrast Visibility May Be Issue for Parkinson's Drivers</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Low-Contrast-Visibility-May-Be-Issue-for-Parkinson/ArticleNewsFeed/Article/detail/631866?contextCategoryId=41766&amp;ref=25</link>

    <description>Drivers with Parkinson's disease may be more prone to poor vehicle control and crashes while driving
    in low-contrast visibility conditions due to issues with perception, cognition and motor dysfunction, according to
    a study in the Oct. 6 issue of Neurology.</description>

    <dc:date>2009-10-06T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631866/elderly_driver.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631866null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Visual-Loss-Lower-in-Recently-Diagnosed-Type-1-Dia/ArticleNewsFeed/Article/detail/632032?contextCategoryId=41766&amp;ref=25">

    <title>Visual Loss Lower in Recently Diagnosed Type 1 Diabetics</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Visual-Loss-Lower-in-Recently-Diagnosed-Type-1-Dia/ArticleNewsFeed/Article/detail/632032?contextCategoryId=41766&amp;ref=25</link>

    <description>People diagnosed with type 1 diabetes mellitus in more recent years have less prevalence of visual
    impairment than those diagnosed earlier, according to a study in the October issue of Ophthalmology.</description>

    <dc:date>2009-10-06T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/632032/eyechart_59082.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/632032null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Clinical+News/FDA-approves-Sirions-NDA-for-ganciclovir-015-for-h/ArticleStandard/Article/detail/631228?contextCategoryId=41766&amp;ref=25">

    <title>FDA approves Sirion's NDA for ganciclovir 0.15% for herpetic keratitis</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Clinical+News/FDA-approves-Sirions-NDA-for-ganciclovir-015-for-h/ArticleStandard/Article/detail/631228?contextCategoryId=41766&amp;ref=25</link>

    <description>The FDA has approved a new drug application (NDA) for ganciclovir ophthalmic gel 0.15% (Zirgan, Sirion
    Therapeutics) as a treatment for acute herpetic keratitis (dendritic ulcers), the company announced.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/412009/631228null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/September-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/630888?contextCategoryId=41766&amp;ref=25">

    <title>September 2009 Briefing - Ophthalmology</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/September-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/630888?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/630888null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Better-Stove-May-Improve-Womens-Respiratory-Health/ArticleNewsFeed/Article/detail/629587?contextCategoryId=41766&amp;ref=25">

    <title>Better Stove May Improve Women's Respiratory Health</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Better-Stove-May-Improve-Womens-Respiratory-Health/ArticleNewsFeed/Article/detail/629587?contextCategoryId=41766&amp;ref=25</link>

    <description>In rural Mexican women, use of an improved wood-burning stove is associated with better respiratory
    function compared to a traditional open fire, according to a study in the Oct. 1 issue of the American Journal of
    Respiratory and Critical Care Medicine.</description>

    <dc:date>2009-09-28T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629587/respiratory.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629587null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Nursing/Childhood-Nephrotic-Syndrome-Can-Cause-Lifelong-Il/ArticleNewsFeed/Article/detail/629418?contextCategoryId=41766&amp;ref=25">

    <title>Childhood Nephrotic Syndrome Can Cause Lifelong Ills</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Nursing/Childhood-Nephrotic-Syndrome-Can-Cause-Lifelong-Il/ArticleNewsFeed/Article/detail/629418?contextCategoryId=41766&amp;ref=25</link>

    <description>Children with minimal-change nephrotic syndrome are at increased risk for osteoporosis, hypertension,
    sperm abnormalities and cataracts if the condition persists beyond puberty, according to a study published online
    Sept. 24 in the Clinical Journal of the American Society of Nephrology.</description>

    <dc:date>2009-09-25T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629418/kidney2.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629418null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Triamcinolone-Studied-for-Vision-Loss-in-Macular-E/ArticleNewsFeed/Article/detail/626778?contextCategoryId=41766&amp;ref=25">

    <title>Triamcinolone Studied for Vision Loss in Macular Edema</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Triamcinolone-Studied-for-Vision-Loss-in-Macular-E/ArticleNewsFeed/Article/detail/626778?contextCategoryId=41766&amp;ref=25</link>

    <description>Intravitreal triamcinolone may improve visual acuity in patients with vision loss associated with
    macular edema due to perfused central retinal vein occlusion, but doesn't appear to improve visual acuity better
    than standard care in patients with macular edema secondary to branch retinal vein occlusion, according to research
    published in the September Archives of Ophthalmology.</description>

    <dc:date>2009-09-15T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/626778/eyechart_SS36019.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/626778null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Corneal-Transplant-Method-Appears-Safe-and-Effecti/ArticleNewsFeed/Article/detail/624688?contextCategoryId=41766&amp;ref=25">

    <title>Corneal Transplant Method Appears Safe and Effective</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Corneal-Transplant-Method-Appears-Safe-and-Effecti/ArticleNewsFeed/Article/detail/624688?contextCategoryId=41766&amp;ref=25</link>

    <description>A form of corneal transplantation to treat eye conditions characterized by corneal endothelial
    dysfunction is safe and effective, according to a review in the September issue of Ophthalmology.</description>

    <dc:date>2009-09-08T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372009/624688/Sen002ml.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372009/624688null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antibiotic-Class-Linked-to-Double-Vision/ArticleNewsFeed/Article/detail/624692?contextCategoryId=41766&amp;ref=25">

    <title>Antibiotic Class Linked to Double Vision</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antibiotic-Class-Linked-to-Double-Vision/ArticleNewsFeed/Article/detail/624692?contextCategoryId=41766&amp;ref=25</link>

    <description>The use of fluoroquinolone antibiotics is associated with double vision, according to a study in the
    September issue of Ophthalmology.</description>

    <dc:date>2009-09-08T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372009/624692/cipro.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/372009/624692null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Sodium-hyaluronate-solution-safe-effective/ArticleStandard/Article/detail/627671?contextCategoryId=41766&amp;ref=25">

    <title>Study: Sodium hyaluronate solution safe, effective</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Sodium-hyaluronate-solution-safe-effective/ArticleStandard/Article/detail/627671?contextCategoryId=41766&amp;ref=25</link>

    <description>An investigational compound for the treatment of dry eye disease consisting of a proprietary
    formulation of sodium hyaluronate ophthalmic solution 0.18% (Vismed, Lantibio Inc.) was shown to be safe and
    effective in a multicenter phase III trial conducted in the United States. A new drug application has been filed
    for the solution, which is already marketed in parts of Europe and Asia as a viscoelastic lubricant eye
    drop.</description>

    <dc:date>2009-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/382009/627671null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/August-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/623314?contextCategoryId=41766&amp;ref=25">

    <title>August 2009 Briefing - Ophthalmology</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/August-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/623314?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623314null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-disease-more-common-in-American-men-as-the/ArticleStandard/Article/detail/627288?contextCategoryId=41766&amp;ref=25">

    <title>Dry eye disease more common in American men as they age</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-disease-more-common-in-American-men-as-the/ArticleStandard/Article/detail/627288?contextCategoryId=41766&amp;ref=25</link>

    <description>A study conducted at Brigham and Women's Hospital (BWH) has found that dry eye disease is common among
    American men aged more than 50 years, and it increases with age, high blood pressure, occurrence of benign prostate
    disease, and the use of antidepressants.</description>

    <dc:date>2009-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/optometrytimes/382009/627288null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pluripotent-Stem-Cells-Aid-in-Exploring-Retinal-De/ArticleNewsFeed/Article/detail/623035?contextCategoryId=41766&amp;ref=25">

    <title>Pluripotent Stem Cells Aid in Exploring Retinal Development</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pluripotent-Stem-Cells-Aid-in-Exploring-Retinal-De/ArticleNewsFeed/Article/detail/623035?contextCategoryId=41766&amp;ref=25</link>

    <description>Human induced pluripotent stem cells may generate retina-specific cell types along a similar time
    schedule as human embryonic stem cells, which may point to therapies for retinal degenerative diseases, according
    to research published Aug. 25 in the Proceedings of the National Academy of Sciences.</description>

    <dc:date>2009-08-31T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623035/eye_SS36015.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623035null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Healing-Impaired-in-Leaking-Blebs-After-Glaucoma-S/ArticleNewsFeed/Article/detail/620722?contextCategoryId=41766&amp;ref=25">

    <title>Healing Impaired in Leaking Blebs After Glaucoma Surgery</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Healing-Impaired-in-Leaking-Blebs-After-Glaucoma-S/ArticleNewsFeed/Article/detail/620722?contextCategoryId=41766&amp;ref=25</link>

    <description>After filtration surgery for glaucoma, mitomycin C-treated filtering blebs with persistent leaks often
    display aberrant wound healing, according to a study in the August issue of the Archives of
    Ophthalmology.</description>

    <dc:date>2009-08-20T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342009/620722/eye_SS36015.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342009/620722null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Scleral-Invasion-Linked-to-Risk-of-Relapse-in-Reti/ArticleNewsFeed/Article/detail/620720?contextCategoryId=41766&amp;ref=25">

    <title>Scleral Invasion Linked to Risk of Relapse in Retinoblastoma</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Scleral-Invasion-Linked-to-Risk-of-Relapse-in-Reti/ArticleNewsFeed/Article/detail/620720?contextCategoryId=41766&amp;ref=25</link>

    <description>Microscopic scleral invasion is uncommon in patients with retinoblastoma, but these patients are at
    risk of extraocular relapse and have better outcomes if they receive high-intensity chemotherapy, according to a
    study in the August issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-08-20T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342009/620720/Sen002ml.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342009/620720null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Uveal-Melanoma-Thickness-Associated-With-Metastasi/ArticleNewsFeed/Article/detail/618538?contextCategoryId=41766&amp;ref=25">

    <title>Uveal Melanoma Thickness Associated With Metastasis</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Uveal-Melanoma-Thickness-Associated-With-Metastasi/ArticleNewsFeed/Article/detail/618538?contextCategoryId=41766&amp;ref=25</link>

    <description>Increasing tumor thickness of uveal melanoma is associated with a higher risk of metastasis and
    therefore may be an important indicator for patient prognosis, according to data published in the August issue of
    the Archives of Ophthalmology.</description>

    <dc:date>2009-08-12T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/332009/618538/sen013.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/332009/618538null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Bevacizumab-Benefits-Seen-in-Forms-of-Macular-Edem/ArticleNewsFeed/Article/detail/617422?contextCategoryId=41766&amp;ref=25">

    <title>Bevacizumab Benefits Seen in Forms of Macular Edema</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Bevacizumab-Benefits-Seen-in-Forms-of-Macular-Edem/ArticleNewsFeed/Article/detail/617422?contextCategoryId=41766&amp;ref=25</link>

    <description>Intravitreal injections of bevacizumab may be useful in treating diffuse diabetic macular edema and
    refractory cystoid macular edema, according to the results of two studies in the August
    Ophthalmology.</description>

    <dc:date>2009-08-06T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/617422/eyeexam_18202.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/617422null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Endocrinology/Cataract-Surgery-Associated-With-Diabetic-Eye-Prob/ArticleNewsFeed/Article/detail/617424?contextCategoryId=41766&amp;ref=25">

    <title>Cataract Surgery Associated With Diabetic Eye Problem</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Endocrinology/Cataract-Surgery-Associated-With-Diabetic-Eye-Prob/ArticleNewsFeed/Article/detail/617424?contextCategoryId=41766&amp;ref=25</link>

    <description>Phacoemulsification surgery for cataracts in patients with diabetes is associated with higher rates of
    new or progressing diabetic retinopathy in the following year, according to research published in the August issue
    of Ophthalmology.</description>

    <dc:date>2009-08-06T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/617424/eyechart_59082.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/617424null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/July-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/615999?contextCategoryId=41766&amp;ref=25">

    <title>July 2009 Briefing - Ophthalmology</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/July-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/615999?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-08-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/615999null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Blepharitis-prevalence-and-management-studied-in-r/ArticleStandard/Article/detail/617067?contextCategoryId=41766&amp;ref=25">

    <title>Blepharitis prevalence and management studied in recent surveys</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Blepharitis-prevalence-and-management-studied-in-r/ArticleStandard/Article/detail/617067?contextCategoryId=41766&amp;ref=25</link>

    <description>Recent surveys of patients and eye care specialists were undertaken to obtain information about the
    prevalence and management of blepharitis. Survey results together with clinical trial data highlight use of topical
    azithromycin.</description>

    <dc:date>2009-08-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/322009/617067null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Endocrinology/Type-1-Diabetes-Complications-Becoming-Less-Common/ArticleNewsFeed/Article/detail/614917?contextCategoryId=41766&amp;ref=25">

    <title>Type 1 Diabetes Complications Becoming Less Common</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Endocrinology/Type-1-Diabetes-Complications-Becoming-Less-Common/ArticleNewsFeed/Article/detail/614917?contextCategoryId=41766&amp;ref=25</link>

    <description>Intensive therapy to treat type 1 diabetes mellitus reduces the frequency of serious complications
    over the long term, according to a study published in the July 27 issue of the Archives of Internal
    Medicine.</description>

    <dc:date>2009-07-29T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/614917/diabetes2.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/614917null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antihypertensive-Drugs-Associated-With-Cataracts/ArticleNewsFeed/Article/detail/613458?contextCategoryId=41766&amp;ref=25">

    <title>Antihypertensive Drugs Associated With Cataracts</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Antihypertensive-Drugs-Associated-With-Cataracts/ArticleNewsFeed/Article/detail/613458?contextCategoryId=41766&amp;ref=25</link>

    <description>Patients treated with beta blockers for hypertension are more likely than their counterparts not using
    the drugs to develop cataracts and require cataract surgery, according to a study published online July 23 in the
    British Journal of Ophthalmology.</description>

    <dc:date>2009-07-23T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/613458/eye_SS36015.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/613458null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Post-LASIK-healing-rate-may-be-increased-by-hyprom/ArticleStandard/Article/detail/610905?contextCategoryId=41766&amp;ref=25">

    <title>Post-LASIK healing rate may be increased by hypromellose gel</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Post-LASIK-healing-rate-may-be-increased-by-hyprom/ArticleStandard/Article/detail/610905?contextCategoryId=41766&amp;ref=25</link>

    <description>Hypromellose 0.3% gel (GenTeal Gel, Novartis Ophthalmics) may increase the rate of
    re-epithelialization of the gutter around LASIK flaps during the first postoperative week.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610905null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patients-with-dry-eye-find-symptom-relief-quality-/ArticleStandard/Article/detail/610903?contextCategoryId=41766&amp;ref=25">

    <title>Patients with dry eye find symptom relief, quality of life improvement with insert, study finds</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patients-with-dry-eye-find-symptom-relief-quality-/ArticleStandard/Article/detail/610903?contextCategoryId=41766&amp;ref=25</link>

    <description>Use of a proprietary hydroxypropyl cellulose ophthalmic insert (Lacrisert, Aton Pharma) in patients
    with dry eye syndrome can improve dry eye symptoms and significantly improve the quality of life for these
    patients, according to a recent study.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610903null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/When-using-punctal-plugs-for-dry-eye-surgeon-favor/ArticleStandard/Article/detail/610889?contextCategoryId=41766&amp;ref=25">

    <title>When using punctal plugs for dry eye, surgeon favors traditional silicone devices</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/When-using-punctal-plugs-for-dry-eye-surgeon-favor/ArticleStandard/Article/detail/610889?contextCategoryId=41766&amp;ref=25</link>

    <description>When faced with a decision about which type of punctal plug to use in the management of dry eye, one
    oculofacial plastic surgeon said she turns to traditional occluders made of silicone because they have a long track
    record and are easily visualized for removal, if necessary. She has not used intracanalicular plugs made of
    polyglycolic acid or hydrogel but said they seem promising.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610889null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Osmometer-comparison-shows-newer-technology-allows/ArticleStandard/Article/detail/610893?contextCategoryId=41766&amp;ref=25">

    <title>Osmometer comparison shows newer technology allows faster, easier measurement</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Osmometer-comparison-shows-newer-technology-allows/ArticleStandard/Article/detail/610893?contextCategoryId=41766&amp;ref=25</link>

    <description>A head-to-head comparison of an older nanoliter osmometer (Clifton Technical Physics) and a newer
    osmometer (OcuSense) shows that both devices are effective in measuring tear osmolarity and produce comparable
    measurements. The newer device has great potential for office clinical use, because readings can be taken very
    easily and quickly by a non-trained individual, according to one doctor.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610893null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Epinastine-HCl-shows-utility-in-dry-eye-allergy/ArticleStandard/Article/detail/610895?contextCategoryId=41766&amp;ref=25">

    <title>Epinastine HCl shows utility in dry eye, allergy</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Epinastine-HCl-shows-utility-in-dry-eye-allergy/ArticleStandard/Article/detail/610895?contextCategoryId=41766&amp;ref=25</link>

    <description>Dry eye disease is a common concomitant finding in patients with allergic conjunctivitis. Treatment
    selection can be challenging because some anti-allergy agents with antihistaminic activity can cause ocular surface
    drying.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610895null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Intraductal-meibomian-gland-probing-reduces-inflam/ArticleStandard/Article/detail/610890?contextCategoryId=41766&amp;ref=25">

    <title>Intraductal meibomian gland probing reduces inflammation quickly, results show</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Intraductal-meibomian-gland-probing-reduces-inflam/ArticleStandard/Article/detail/610890?contextCategoryId=41766&amp;ref=25</link>

    <description>A new technique of intraductal meibomian gland probing using disposable cannulas of various lengths
    appears highly effective in providing quick and lasting relief from inflammatory symptoms of obstructive meibomian
    gland disease.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610890null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-progression-prevented-by-cyclosporine/ArticleStandard/Article/detail/610891?contextCategoryId=41766&amp;ref=25">

    <title>Dry eye progression prevented by cyclosporine</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-progression-prevented-by-cyclosporine/ArticleStandard/Article/detail/610891?contextCategoryId=41766&amp;ref=25</link>

    <description>A recent study showed that moderate to severe dry eye disease can be best treated with
    anti-inflammatory medications such as topical cyclosporine. According to one ophthalmologist, cyclosporine can
    significantly limit progression of dry eye disease and should be considered a &amp;#34;go-to&amp;#34; therapy in
    this patient population.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610891null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/PostLASIK-dry-eye-treatment-using-sodium-hyalurona/ArticleStandard/Article/detail/610904?contextCategoryId=41766&amp;ref=25">

    <title>PostLASIK dry eye treatment using sodium hyaluronate-based artificial tear found beneficial</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/PostLASIK-dry-eye-treatment-using-sodium-hyalurona/ArticleStandard/Article/detail/610904?contextCategoryId=41766&amp;ref=25</link>

    <description>The benefits of two artificial tear products were compared in a head-to-head, randomized,
    contralateral eye-controlled study enrolling 40 patients undergoing bilateral LASIK. Wavefront analysis was used
    for the primary outcome assessment of quality of vision and favored use of a sodium hyaluronate-based product
    (Blink Tears, Abbott Medical Optics).</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610904null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Posterior-Chamber-Lens-Shows-Years-of-Benefit-in-M/ArticleNewsFeed/Article/detail/611377?contextCategoryId=41766&amp;ref=25">

    <title>Posterior Chamber Lens Shows Years of Benefit in Myopia</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Posterior-Chamber-Lens-Shows-Years-of-Benefit-in-M/ArticleNewsFeed/Article/detail/611377?contextCategoryId=41766&amp;ref=25</link>

    <description>Implantable Collamer lenses appear safe, efficacious and stable for treating moderate to high myopia
    over four years of follow-up, according to research published in the July issue of the Archives of
    Ophthalmology.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/292009/611377/SS36001.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/292009/611377null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Artificial-tear-product-improves-functional-visual/ArticleStandard/Article/detail/610896?contextCategoryId=41766&amp;ref=25">

    <title>Artificial tear product improves functional visual performance on intensive tasks</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Artificial-tear-product-improves-functional-visual/ArticleStandard/Article/detail/610896?contextCategoryId=41766&amp;ref=25</link>

    <description>An evaluation of functional visual performance of two currently marketed artificial tear products
    using the interblink interval visual acuity decay method showed that a tear with a polyethylene glycol/propylene
    glycol (PEG/PG)-based formulation (Systane Ultra, Alcon Laboratories) resulted in a statistically significant
    increase in the length of time within one line of best-corrected visual acuity (BCVA) within an interblink period
    at 90 minutes after instillation of a single drop. The drop was compared with a
    carboxymethylcellulose/glycerin-based tear (Optive, Allergan). Median times to one-line loss of BCVA were not
    statistically different at the timepoints of 15 or 45 minutes post-instillation.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610896null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-drop-formulation-found-effective-for-post-LASI/ArticleStandard/Article/detail/610897?contextCategoryId=41766&amp;ref=25">

    <title>Eye drop formulation found effective for post-LASIK dry eye</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-drop-formulation-found-effective-for-post-LASI/ArticleStandard/Article/detail/610897?contextCategoryId=41766&amp;ref=25</link>

    <description>Optive Sensitive (Allergan) was safe and effective for the management of dry eye signs and symptoms
    after LASIK surgery and may have some incremental benefits over standard tear management.</description>

    <dc:date>2009-07-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/292009/610897null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Inflammation-Is-Linked-to-Corneal-Transplant-Rejec/ArticleNewsFeed/Article/detail/609607?contextCategoryId=41766&amp;ref=25">

    <title>Inflammation Is Linked to Corneal Transplant Rejection</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Inflammation-Is-Linked-to-Corneal-Transplant-Rejec/ArticleNewsFeed/Article/detail/609607?contextCategoryId=41766&amp;ref=25</link>

    <description>For patients receiving a corneal transplant for herpes simplex virus keratitis, signs of inflammation
    in excised corneal tissue detected in a histopathologic examination indicate increased risk for allograft
    rejection, according to a study in the July issue of Ophthalmology.</description>

    <dc:date>2009-07-08T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/282009/609607/Sen002ml.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/282009/609607null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/June-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/608156?contextCategoryId=41766&amp;ref=25">

    <title>June 2009 Briefing - Ophthalmology</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/June-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/608156?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-07-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/608156null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-diagnosis-could-be-aided-by-tear-osmolarit/ArticleStandard/Article/detail/606431?contextCategoryId=41766&amp;ref=25">

    <title>Dry eye diagnosis could be aided by tear osmolarity device</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-diagnosis-could-be-aided-by-tear-osmolarit/ArticleStandard/Article/detail/606431?contextCategoryId=41766&amp;ref=25</link>

    <description>The FDA has given 501(k) clearance to the TearLab Osmolarity System, a new device that measures the
    osmolarity of tears to aid in the diagnosis of dry eye disease.</description>

    <dc:date>2009-07-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/262009/606431null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Protein-Target-Key-to-Prevent-Macular-Degenera/ArticleNewsFeed/Article/detail/604536?contextCategoryId=41766&amp;ref=25">

    <title>New Protein Target Key to Prevent Macular Degeneration</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Protein-Target-Key-to-Prevent-Macular-Degenera/ArticleNewsFeed/Article/detail/604536?contextCategoryId=41766&amp;ref=25</link>

    <description>Blocking the activity of the protein eosinophil/mast cell chemokine receptor can reduce the abnormal
    blood vessel growth that leads to age-related macular degeneration, a leading cause of blindness worldwide,
    according to a study published online June 14 in Nature.</description>

    <dc:date>2009-06-17T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252009/604536/33101.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252009/604536null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Approaching-the-patient-with-chronic-eye-irritatio/ArticleStandard/Article/detail/601870?contextCategoryId=41766&amp;ref=25">

    <title>Dry eye and blepharitis: Approaching the patient with chronic eye irritation</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Approaching-the-patient-with-chronic-eye-irritatio/ArticleStandard/Article/detail/601870?contextCategoryId=41766&amp;ref=25</link>

    <description>Patients with dry eye experience sandy-gritty irritation, dryness, burning, or increased awareness of
    their eyes that gets worse as the day goes on, whereas patients with posterior blepharitis, or meibomitis, have
    similar symptoms that are worse on eye opening. Treatment includes strategies to lower tear film osmolarity and to
    treat associated eyelid conditions.</description>

    <dc:date>2009-06-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/geriatrics/232009/601870null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Managed+Care/Dry-Eye-Affects-168-Million-Older-Men-in-US/ArticleNewsFeed/Article/detail/603019?contextCategoryId=41766&amp;ref=25">

    <title>Dry Eye Affects 1.68 Million Older Men in U.S.</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Managed+Care/Dry-Eye-Affects-168-Million-Older-Men-in-US/ArticleNewsFeed/Article/detail/603019?contextCategoryId=41766&amp;ref=25</link>

    <description>Dry eye disease affects 1.68 million U.S. men age 50 and older, and those who have high blood
    pressure, an enlarged prostate, or use antidepressants are at elevated risk, according to a study reported in the
    June Archives of Ophthalmology.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/242009/603019/33101.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/242009/603019null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Childhood-Eye-Condition-Linked-to-Psychiatric-Diso/ArticleNewsFeed/Article/detail/602761?contextCategoryId=41766&amp;ref=25">

    <title>Childhood Eye Condition Linked to Psychiatric Disorders</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Childhood-Eye-Condition-Linked-to-Psychiatric-Diso/ArticleNewsFeed/Article/detail/602761?contextCategoryId=41766&amp;ref=25</link>

    <description>Children with the eye condition intermittent exotropia have a nearly three-fold increase in risk for a
    mental health disorder in adulthood, according to a study in the June issue of the Archives of
    Ophthalmology.</description>

    <dc:date>2009-06-10T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/242009/602761/15339.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/242009/602761null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-Bacteria-Getting-More-Resistant-to-Older-Antib/ArticleNewsFeed/Article/detail/601743?contextCategoryId=41766&amp;ref=25">

    <title>Eye Bacteria Getting More Resistant to Older Antibiotics</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-Bacteria-Getting-More-Resistant-to-Older-Antib/ArticleNewsFeed/Article/detail/601743?contextCategoryId=41766&amp;ref=25</link>

    <description>Conjunctival bacteria are becoming increasingly resistant to earlier generation
    &amp;amp;amp;#64258;uoroquinolone antibiotics, and eye surgeons should switch to newer antibiotics to prevent
    dangerous post-surgical infections, according to a study in the June issue of Ophthalmology.</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/601743/Sen002ml.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/601743null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patient-Factors-Identified-Affecting-Corneal-Graft/ArticleNewsFeed/Article/detail/601808?contextCategoryId=41766&amp;ref=25">

    <title>Patient Factors Identified Affecting Corneal Graft Failure</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patient-Factors-Identified-Affecting-Corneal-Graft/ArticleNewsFeed/Article/detail/601808?contextCategoryId=41766&amp;ref=25</link>

    <description>Corneal grafts are more apt to fail in patients with a diagnosis of aphakic or pseudophakic corneal
    edema or in patients who have had prior glaucoma surgery and treatment, according to a study in the June issue of
    Ophthalmology.</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/601808/eye_40179.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/601808null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patient-Factors-Affect-Glaucoma-Eyedrop-Adherence/ArticleNewsFeed/Article/detail/601476?contextCategoryId=41766&amp;ref=25">

    <title>Patient Factors Affect Glaucoma Eyedrop Adherence</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patient-Factors-Affect-Glaucoma-Eyedrop-Adherence/ArticleNewsFeed/Article/detail/601476?contextCategoryId=41766&amp;ref=25</link>

    <description>Poor adherence to glaucoma eyedrop therapy is associated with various patient factors, including age,
    race, income, treatment knowledge, and self-reported physical and mental health, according to a study in June issue
    of Ophthalmology.</description>

    <dc:date>2009-06-03T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/601476/eyedrop_59237.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/601476null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/May-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/600952?contextCategoryId=41766&amp;ref=25">

    <title>May 2009 Briefing - Ophthalmology</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/May-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/600952?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/600952null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleNewsFeed/Article/detail/598381?contextCategoryId=41766&amp;ref=25">

    <title>Association for Research in Vision and Ophthalmology, May 3-7, 2009</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Association-for-Research-in-Vision-and-Ophthalmolo/ArticleNewsFeed/Article/detail/598381?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/202009/598381null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Key-Nutrients-Lower-Risk-of-Macular-Degeneration/ArticleNewsFeed/Article/detail/597339?contextCategoryId=41766&amp;ref=25">

    <title>Key Nutrients Lower Risk of Macular Degeneration</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Key-Nutrients-Lower-Risk-of-Macular-Degeneration/ArticleNewsFeed/Article/detail/597339?contextCategoryId=41766&amp;ref=25</link>

    <description>The intake of certain key nutrients can reduce the risk of age-related macular degeneration and that
    risk can be correlated with a nutrient compound score devised by researchers and reported in the May issue of
    Ophthalmology.</description>

    <dc:date>2009-05-08T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/192009/597339/eyeinjury_18203.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/192009/597339null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/April-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/596174?contextCategoryId=41766&amp;ref=25">

    <title>April 2009 Briefing - Ophthalmology</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/April-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/596174?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/182009/596174null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ophthalmologys-underserved-areas-to-be-addressed-b/ArticleStandard/Article/detail/599641?contextCategoryId=41766&amp;ref=25">

    <title>Ophthalmology's underserved areas to be addressed by pharmaceutical pipeline</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ophthalmologys-underserved-areas-to-be-addressed-b/ArticleStandard/Article/detail/599641?contextCategoryId=41766&amp;ref=25</link>

    <description>The pharmaceutical pipeline is addressing many underserved areas of ophthalmology, such as dry
    age-related macular degeneration (AMD) and dry eye, and new compounds are being studied to replace or augment the
    variety of therapeutics already available for wet AMD and glaucoma.</description>

    <dc:date>2009-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/222009/599641null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Clinical+News/Cyclosporine-for-dry-eye-shows-significant-improve/ArticleStandard/Article/detail/596113?contextCategoryId=41766&amp;ref=25">

    <title>Cyclosporine for dry eye shows significant improvement in symptoms, according to phase II study</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Clinical+News/Cyclosporine-for-dry-eye-shows-significant-improve/ArticleStandard/Article/detail/596113?contextCategoryId=41766&amp;ref=25</link>

    <description>Phase II of a clinical study examining a formulation of cyclosporine (Cyclokat, Novagali Pharma) has
    been completed, and results demonstrate statistically significant improvement with signs and symptoms in patients
    suffering from moderate-to-severe dry eye syndrome.</description>

    <dc:date>2009-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/182009/596113null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Drugs-Effect-on-Macular-Edema-in-Type-2-Diabetics-/ArticleNewsFeed/Article/detail/593948?contextCategoryId=41766&amp;ref=25">

    <title>Drug's Effect on Macular Edema in Type 2 Diabetics Studied</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Drugs-Effect-on-Macular-Edema-in-Type-2-Diabetics-/ArticleNewsFeed/Article/detail/593948?contextCategoryId=41766&amp;ref=25</link>

    <description>In patients with type 2 diabetes who have mild-to-moderate non-proliferative diabetic retinopathy,
    calcium dobesilate does not reduce the risk of development of clinically significant macular edema, according to a
    study published in the April 18 issue of The Lancet.</description>

    <dc:date>2009-04-17T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593948/eye_SS36015.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593948null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Stem-Cells-Repair-Corneal-Damage-in-Mice/ArticleNewsFeed/Article/detail/593862?contextCategoryId=41766&amp;ref=25">

    <title>Stem Cells Repair Corneal Damage in Mice</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Stem-Cells-Repair-Corneal-Damage-in-Mice/ArticleNewsFeed/Article/detail/593862?contextCategoryId=41766&amp;ref=25</link>

    <description>Stem cells from human corneas can be used in a mouse model to treat corneal scarring resulting from
    trauma or inflammation that can lead to blindness, according to a study published online April 9 in Stem
    Cells.</description>

    <dc:date>2009-04-16T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593862/eyeinjury_18203.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593862null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Vision-Safety-of-Erectile-Dysfunction-Drugs-Examin/ArticleNewsFeed/Article/detail/593483?contextCategoryId=41766&amp;ref=25">

    <title>Vision Safety of Erectile Dysfunction Drugs Examined</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Vision-Safety-of-Erectile-Dysfunction-Drugs-Examin/ArticleNewsFeed/Article/detail/593483?contextCategoryId=41766&amp;ref=25</link>

    <description>Daily use of phosphodiesterase type 5 inhibitors in men with mild erectile dysfunction is not
    associated with abnormalities in electroretinography or visual function, according to research published in the
    April issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-04-15T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593483/eye_40179.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593483null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Repetitive-Training-Offers-Benefits-After-Cortex-D/ArticleNewsFeed/Article/detail/592194?contextCategoryId=41766&amp;ref=25">

    <title>Repetitive Training Offers Benefits After Cortex Damage</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Repetitive-Training-Offers-Benefits-After-Cortex-D/ArticleNewsFeed/Article/detail/592194?contextCategoryId=41766&amp;ref=25</link>

    <description>Repetitive training appears effective for improving visual motion processing in the blind field of
    adults with primary visual cortex damage, according to research published in the April 1 issue of the Journal of
    Neuroscience.</description>

    <dc:date>2009-04-07T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/592194/eye_SS36006.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/592194null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/About-3-Percent-of-US-Children-Have-Hearing-Loss/ArticleNewsFeed/Article/detail/592195?contextCategoryId=41766&amp;ref=25">

    <title>About 3 Percent of US Children Have Hearing Loss</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/About-3-Percent-of-US-Children-Have-Hearing-Loss/ArticleNewsFeed/Article/detail/592195?contextCategoryId=41766&amp;ref=25</link>

    <description>About 3 percent of children and adolescents in the United States have hearing loss, although
    definitions of hearing loss vary, according to a study in the April issue of Otolaryngology - Head and Neck
    Surgery. In a related study, published in April's Ophthalmology, refractive errors in urban preschoolers, although
    uncommon, may not be identified and corrected.</description>

    <dc:date>2009-04-07T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/592195/SEN055.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/592195null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/LASIK-Linked-to-High-Patient-Satisfaction-Rates/ArticleNewsFeed/Article/detail/591830?contextCategoryId=41766&amp;ref=25">

    <title>LASIK Linked to High Patient Satisfaction Rates</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/LASIK-Linked-to-High-Patient-Satisfaction-Rates/ArticleNewsFeed/Article/detail/591830?contextCategoryId=41766&amp;ref=25</link>

    <description>Most patients report that they are satisfied with the results of LASIK surgery, which is the most
    commonly performed elective procedure, according to research published in the April issue of
    Ophthalmology.</description>

    <dc:date>2009-04-06T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/591830/Sen002ml.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/591830null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Inhaled-and-Oral-Corticosteroid-Link-to-Cataracts-/ArticleNewsFeed/Article/detail/591521?contextCategoryId=41766&amp;ref=25">

    <title>Inhaled and Oral Corticosteroid Link to Cataracts Examined</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Inhaled-and-Oral-Corticosteroid-Link-to-Cataracts-/ArticleNewsFeed/Article/detail/591521?contextCategoryId=41766&amp;ref=25</link>

    <description>Individuals who use both inhaled and oral corticosteroids may face increased long-term risks of
    posterior subcapsular cataracts and nuclear cataracts, according to research published in the April issue of
    Ophthalmology.</description>

    <dc:date>2009-04-03T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/142009/591521/eyechart.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/142009/591521null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/March-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/590883?contextCategoryId=41766&amp;ref=25">

    <title>March 2009 Briefing - Ophthalmology</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/March-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/590883?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/272009/590883null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laser-vision-correction-procedures-improved-by-pha/ArticleStandard/Article/detail/593677?contextCategoryId=41766&amp;ref=25">

    <title>Laser vision-correction procedures improved by pharmacologic strategies</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laser-vision-correction-procedures-improved-by-pha/ArticleStandard/Article/detail/593677?contextCategoryId=41766&amp;ref=25</link>

    <description>Oral and topical medications are an important part of the management of patients undergoing laser
    vision-correction procedures. Their uses include the treatment and/or prevention of dry eye, haze, regression, and
    pain.</description>

    <dc:date>2009-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/162009/593677null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Mass-Antibiotic-Program-Can-Offer-Trachoma-Herd-Pr/ArticleNewsFeed/Article/detail/589743?contextCategoryId=41766&amp;ref=25">

    <title>Mass Antibiotic Program Can Offer Trachoma Herd Protection</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Mass-Antibiotic-Program-Can-Offer-Trachoma-Herd-Pr/ArticleNewsFeed/Article/detail/589743?contextCategoryId=41766&amp;ref=25</link>

    <description>Herd immunity to trachoma can be achieved through repeated rounds of mass antibiotic administration to
    children, who are a core means of transmission for the eye disease, according to a report published in the March 28
    issue of The Lancet.</description>

    <dc:date>2009-03-27T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/132009/589743/eye_SS36015.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/132009/589743null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/US-Diabetic-Retinopathy-Cases-Set-to-Triple-by-205/ArticleNewsFeed/Article/detail/586610?contextCategoryId=41766&amp;ref=25">

    <title>US Diabetic Retinopathy Cases Set to Triple by 2050</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/US-Diabetic-Retinopathy-Cases-Set-to-Triple-by-205/ArticleNewsFeed/Article/detail/586610?contextCategoryId=41766&amp;ref=25</link>

    <description>As the number of Americans with diabetes continues to rise, so will the incidence of diabetes-related
    eye diseases such as diabetic retinopathy, cataracts and glaucoma, according to an editorial published in the March
    issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-03-11T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/586610/eye_SS36015.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/586610null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Insurance-Status-Affects-Access-to-Eye-Care/ArticleNewsFeed/Article/detail/586067?contextCategoryId=41766&amp;ref=25">

    <title>Insurance Status Affects Access to Eye Care</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Insurance-Status-Affects-Access-to-Eye-Care/ArticleNewsFeed/Article/detail/586067?contextCategoryId=41766&amp;ref=25</link>

    <description>Uninsured Americans are far less likely than their insured counterparts to seek the services of an eye
    care professional, researchers report in the March issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-03-10T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/586067/eyechart.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/586067null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Macular-Degeneration-Linked-with-Range-of-Illnesse/ArticleNewsFeed/Article/detail/586065?contextCategoryId=41766&amp;ref=25">

    <title>Macular Degeneration Linked with Range of Illnesses</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Macular-Degeneration-Linked-with-Range-of-Illnesse/ArticleNewsFeed/Article/detail/586065?contextCategoryId=41766&amp;ref=25</link>

    <description>Elderly patients with age-related macular degeneration are more likely than their counterparts without
    the eye disease to experience a wide range of illnesses, including depression, hip fracture and blindness,
    according to a report published in the March issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-03-10T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/586065/eyeexam_18202.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/586065null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/February-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/584213?contextCategoryId=41766&amp;ref=25">

    <title>February 2009 Briefing - Ophthalmology</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/February-2009-Briefing---Ophthalmology/ArticleNewsFeed/Article/detail/584213?contextCategoryId=41766&amp;ref=25</link>

    <description />

    <dc:date>2009-03-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/182009/584213null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/For-dry-eye-patients-punctal-plugs-offer-flow-cont/ArticleStandard/Article/detail/585651?contextCategoryId=41766&amp;ref=25">

    <title>For dry eye patients punctal plugs offer flow control</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/For-dry-eye-patients-punctal-plugs-offer-flow-cont/ArticleStandard/Article/detail/585651?contextCategoryId=41766&amp;ref=25</link>

    <description>Soft Plug Flow Control Silicone Plugs (Oasis Medical) provide partial occlusion of the puncta with
    limited tear drainage for patients with moderate and severe dry eye. These plugs eliminate epiphora in patients for
    whom total occlusion is excessive.</description>

    <dc:date>2009-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/102009/585651null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Calcium-Other-Nutrients-May-Reduce-Disease-Risk/ArticleNewsFeed/Article/detail/583396?contextCategoryId=41766&amp;ref=25">

    <title>Calcium, Other Nutrients May Reduce Disease Risk</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Calcium-Other-Nutrients-May-Reduce-Disease-Risk/ArticleNewsFeed/Article/detail/583396?contextCategoryId=41766&amp;ref=25</link>

    <description>Several nutrients were associated with possible protection from cancer and age-related macular
    degeneration, according to two studies published in the Feb. 23 issue of the Archives of Internal
    Medicine.</description>

    <dc:date>2009-02-25T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583396/Sen002ml.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583396null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ocular-Damage-Common-in-Severe-Skin-Reactions/ArticleNewsFeed/Article/detail/582431?contextCategoryId=41766&amp;ref=25">

    <title>Ocular Damage Common in Severe Skin Reactions</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ocular-Damage-Common-in-Severe-Skin-Reactions/ArticleNewsFeed/Article/detail/582431?contextCategoryId=41766&amp;ref=25</link>

    <description>It is common for patients with the rare skin reactions toxic epidermal necrolysis or Stevens-Johnson
    syndrome to also experience involvement of the eyes, according to the results of a study published in the February
    issue of the Archives of Dermatology.</description>

    <dc:date>2009-02-18T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582431/eye_40179.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582431null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-Problems-Found-in-Many-Children-with-Hearing-L/ArticleNewsFeed/Article/detail/582350?contextCategoryId=41766&amp;ref=25">

    <title>Eye Problems Found in Many Children with Hearing Loss</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-Problems-Found-in-Many-Children-with-Hearing-L/ArticleNewsFeed/Article/detail/582350?contextCategoryId=41766&amp;ref=25</link>

    <description>Routine ophthalmologic examinations may be helpful in supporting proper development in children with
    sensorineural hearing loss, according to research published in the February Archives of Otolaryngology -- Head
    &amp;amp;amp; Neck Surgery.</description>

    <dc:date>2009-02-18T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582350/eyeexam_40291.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582350null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ecabet-shows-promise-for-dry-eye-in-phase-IIb-stud/ArticleStandard/Article/detail/582497?contextCategoryId=41766&amp;ref=25">

    <title>Ecabet shows promise for dry eye in phase IIb study results</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ecabet-shows-promise-for-dry-eye-in-phase-IIb-stud/ArticleStandard/Article/detail/582497?contextCategoryId=41766&amp;ref=25</link>

    <description>Ecabet sodium (ISTA Pharmaceuticals), an anti-ulcer and gastritis drug under development for the
    treatment of dry eye, showed positive results in a phase IIb clinical trial of the drug.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582497null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Bepotastine-is-effective-against-allergic-conjunct/ArticleStandard/Article/detail/582491?contextCategoryId=41766&amp;ref=25">

    <title>Bepotastine is effective against allergic conjunctivitis in research</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Bepotastine-is-effective-against-allergic-conjunct/ArticleStandard/Article/detail/582491?contextCategoryId=41766&amp;ref=25</link>

    <description>Bepotastine besilate 1.0% (Bepreve, ISTA Pharmaceuticals), an ocular allergy compound under new drug
    application review by the FDA, is effective in reducing ocular itching associated with allergic conjunctivitis and
    also seems to improve other allergy symptoms.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582491null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-in-patients-undergoing-LASIK-requires-proa/ArticleStandard/Article/detail/582495?contextCategoryId=41766&amp;ref=25">

    <title>Dry eye in patients undergoing LASIK requires proactive approach when detecting, managing</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-in-patients-undergoing-LASIK-requires-proa/ArticleStandard/Article/detail/582495?contextCategoryId=41766&amp;ref=25</link>

    <description>Recognizing and treating dry eye disease before LASIK is an important strategy for mitigating patient
    unhappiness after surgery.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582495null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-and-allergy-clues-are-right-before-your-ey/ArticleStandard/Article/detail/582496?contextCategoryId=41766&amp;ref=25">

    <title>Dry eye and allergy clues are right before your eyes</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-and-allergy-clues-are-right-before-your-ey/ArticleStandard/Article/detail/582496?contextCategoryId=41766&amp;ref=25</link>

    <description>A careful look at all the clues can help the clinician differentiate between dry eye and allergies.
    The patient history may contain the most important clues for establishing a diagnosis.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582496null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anti-allergy-drop-does-not-cause-dryness-to-ocular/ArticleStandard/Article/detail/582493?contextCategoryId=41766&amp;ref=25">

    <title>Anti-allergy drop does not cause dryness to ocular surface, studies show</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anti-allergy-drop-does-not-cause-dryness-to-ocular/ArticleStandard/Article/detail/582493?contextCategoryId=41766&amp;ref=25</link>

    <description>A novel ophthalmic anti-allergy agent, epinastine HCl ophthalmic solution 0.05% (Elestat, Inspire
    Pharmaceuticals), effectively controls ocular allergy in patients with dry eye, according to Jodi Luchs, MD, FACS.
    The drop has been shown to rapidly prevent ocular allergy symptoms by blocking H1 and H2 receptors, stabilizing
    mast cells, and inhibiting the release of proinflammatory mediators.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582493null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ophthalmologists-perception-of-moderate-to-severe-/ArticleStandard/Article/detail/582501?contextCategoryId=41766&amp;ref=25">

    <title>Ophthalmologists' perception of moderate to severe dry eye shown by survey</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ophthalmologists-perception-of-moderate-to-severe-/ArticleStandard/Article/detail/582501?contextCategoryId=41766&amp;ref=25</link>

    <description>Ophthalmologists who responded to questions about treatment of dry eye indicated that there are
    limitations in the available treatment options, especially for patients with moderate to severe cases of the
    disease, and that only 5% of ophthalmologists saw existing treatments as effective for the patients with the worst
    cases.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582501null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-drops-for-contact-lens-wearers-are-found-to-be/ArticleStandard/Article/detail/582498?contextCategoryId=41766&amp;ref=25">

    <title>Eye drops for contact lens wearers are found to be safe</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Eye-drops-for-contact-lens-wearers-are-found-to-be/ArticleStandard/Article/detail/582498?contextCategoryId=41766&amp;ref=25</link>

    <description>A clinical trial tested the safety and efficacy of Optive eye drops (Allergan) in contact lens
    wearers. Participants reported no adverse events and that their lenses were more comfortable to wear; clinical
    assessment found no adverse events or complications after 4 weeks of treatment.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582498null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-common-postLASIK----and-before/ArticleStandard/Article/detail/582499?contextCategoryId=41766&amp;ref=25">

    <title>Dry eye common postLASIK . . . and before</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-common-postLASIK----and-before/ArticleStandard/Article/detail/582499?contextCategoryId=41766&amp;ref=25</link>

    <description>A review of the world literature shows that about one-third of patients who are undergoing LASIK
    already suffer from dry eye, and the proportion affected after surgery is similar. In most cases, however, dry eye
    does not appear to affect postoperative vision and satisfaction outcomes adversely. Identification of patients at
    risk and pre-treating may reduce the postoperative incidence of dry eye.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582499null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lipid-emulsion-benefits-dry-eye-disease-says-docto/ArticleStandard/Article/detail/582500?contextCategoryId=41766&amp;ref=25">

    <title>Lipid emulsion benefits dry eye disease, says doctor</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lipid-emulsion-benefits-dry-eye-disease-says-docto/ArticleStandard/Article/detail/582500?contextCategoryId=41766&amp;ref=25</link>

    <description>A compromised lipid layer plays a key role in the development and perpetuation of dry eye disease
    because it allows increased aqueous evaporation and fails to protect against friction between the blinking lid and
    the ocular surface. A proprietary brand of emollient eye drops (Soothe XP. Bausch &amp;amp;amp; Lomb) was created
    to re-establish the tear film lipid layer and restore moisture, and it is an effective choice for providing
    symptomatic relief in patients with dry eye disease, says one optometrist.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582500null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-drops-and-the-different-implications-for-p/ArticleStandard/Article/detail/582490?contextCategoryId=41766&amp;ref=25">

    <title>Dry-eye drops and the different implications for patients</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-drops-and-the-different-implications-for-p/ArticleStandard/Article/detail/582490?contextCategoryId=41766&amp;ref=25</link>

    <description>Important differences exist between the various classes of over-the-counter eye drops. Physicians play
    a vital role in explaining these differences, as well as their potential implications in the treatment of the
    symptoms of dry eye and other conditions, to patients. Educating patients about the available formulations not only
    may expedite the relief of their symptoms but also may save them time and money.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582490null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-treatment-should-be-tailored-to-patient/ArticleStandard/Article/detail/582492?contextCategoryId=41766&amp;ref=25">

    <title>Dry eye treatment should be tailored to patient</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dry-eye-treatment-should-be-tailored-to-patient/ArticleStandard/Article/detail/582492?contextCategoryId=41766&amp;ref=25</link>

    <description>Dry eye is a chronic disease that requires adjustments to treatment, follow-up, re-testing, monitoring
    of progress, and changes of medication. Treatment should be tailored for each patient.</description>

    <dc:date>2009-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/082009/582492null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Better-Visual-Field-Sight-with-Vigabatrin-During-I/ArticleNewsFeed/Article/detail/580874?contextCategoryId=41766&amp;ref=25">

    <title>Better Visual Field Sight with Vigabatrin During Infancy</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Better-Visual-Field-Sight-with-Vigabatrin-During-I/ArticleNewsFeed/Article/detail/580874?contextCategoryId=41766&amp;ref=25</link>

    <description>Administration of the anti-epileptic drug vigabatrin during infancy compared with later ages may
    reduce the risk of vigabatrin-attributed visual field loss, according to research published in the February issue
    of Epilepsia.</description>

    <dc:date>2009-02-11T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/580874/babyface_SS36035.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/580874null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Topical-Cyclosporine-Beneficial-in-Dry-Eye-Syndrom/ArticleNewsFeed/Article/detail/580745?contextCategoryId=41766&amp;ref=25">

    <title>Topical Cyclosporine Beneficial in Dry Eye Syndrome</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Topical-Cyclosporine-Beneficial-in-Dry-Eye-Syndrom/ArticleNewsFeed/Article/detail/580745?contextCategoryId=41766&amp;ref=25</link>

    <description>In patients with moderate to severe dry eye syndrome who don't respond to conventional lubricant
    therapy, treatment with topical cyclosporine emulsion improves quality of life and is cost-effective, researchers
    report in the February issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-02-10T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/580745/eyedrop_59237.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/580745null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anecortave-Acetate-Reduces-Ocular-Hypertension/ArticleNewsFeed/Article/detail/580603?contextCategoryId=41766&amp;ref=25">

    <title>Anecortave Acetate Reduces Ocular Hypertension</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anecortave-Acetate-Reduces-Ocular-Hypertension/ArticleNewsFeed/Article/detail/580603?contextCategoryId=41766&amp;ref=25</link>

    <description>In eyes with uncontrolled steroid-related ocular hypertension, treatment with anecortave acetate
    results in a safe and rapid reduction of hypertension that persists for up to six months or more, according to the
    results of a small study published in the February issue of the Archives of Ophthalmology.</description>

    <dc:date>2009-02-10T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/580603/Sen002ml.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/580603null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Trichloramine-at-Ohio-Waterpark-Sickened-665-Peopl/ArticleNewsFeed/Article/detail/580441?contextCategoryId=41766&amp;ref=25">

    <title>Trichloramine at Ohio Waterpark Sickened 665 People</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Trichloramine-at-Ohio-Waterpark-Sickened-665-Peopl/ArticleNewsFeed/Article/detail/580441?contextCategoryId=41766&amp;ref=25</link>

    <description>Exposure to airborne trichloramine caused eye and respiratory irritations in 665 people who were
    patrons and lifeguards of an indoor waterpark resort in Ohio, according to a report published in the Feb. 6 issue
    of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.</description>

    <dc:date>2009-02-09T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/580441/swimming_40095.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/580441null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.modernmedicine.com/modernmedicine/Clinical+News/ISTA-announces-results-of-phase-IIb-study-of-ecabe/ArticleStandard/Article/detail/579948?contextCategoryId=41766&amp;ref=25">

    <title>ISTA announces results of phase IIb study of ecabet</title>

    <link>
    http://www.modernmedicine.com/modernmedicine/Clinical+News/ISTA-announces-results-of-phase-IIb-study-of-ecabe/ArticleStandard/Article/detail/579948?contextCategoryId=41766&amp;ref=25</link>

    <description>Patients treated with ecabet sodium demonstrated a strong positive trend in the objective sign of tear
    film break-up time and a positive trend in the objective sign of quantity of tears produced in a phase IIb study
    conducted by ISTA Pharmaceuticals.</description>

    <dc:date>2009-02-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.modernmedicine.com/modernmedicine/data/articlestandard/ophthalmologytimes/062009/579948null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


